This HTML5 document contains 66 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q61969570
rdf:type
wikibase:Item
schema:description
ensayu clínicu clinical trial клінічне випробування klinisch onderzoek
rdfs:label
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
skos:prefLabel
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
schema:name
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
p:P1476
wds:Q61969570-CD45CC05-202F-459D-8D88-DEE74055BAEF
wdt:P1476
A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab in Subjects With Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma
p:P582
wds:Q61969570-769DBDCF-9D38-4100-933F-F5FCE8AF8677
wdt:P582
2023-04-08T00:00:00Z
p:P31
wds:Q61969570-8A952152-2D43-46F8-B58E-1F460B12081C
wdt:P31
wd:Q30612
p:P580
wds:Q61969570-8E38F75E-3496-43F0-8964-B59ACE0AD320
wdt:P580
2014-04-02T00:00:00Z
p:P17
wds:Q61969570-FFDF9407-0964-493F-8810-451CA8F7D824 wds:Q61969570-B57D7053-2BFC-4A16-A510-ED10102ED245
wdt:P17
wd:Q183 wd:Q30
p:P6153
wds:Q61969570-6FC9E644-651F-4280-B7E8-7E47B5414BD2 wds:Q61969570-805DA744-3A59-4D4B-A24F-62B8FEAD11DE wds:Q61969570-B55DB855-DD4A-4A05-B206-76C77C7B260C wds:Q61969570-B0A56F39-1CAC-4370-A766-6016A3578C5D wds:Q61969570-B49C6069-923E-437A-BB11-585382B153EF wds:Q61969570-21B6DA9E-7FEE-43DF-9FA4-BBFECB10BC6E wds:Q61969570-24B75A80-CB37-48C1-8709-623EC128DC06 wds:Q61969570-2D4BB9DC-534A-40FA-9EE2-BD3D39A0EFEC wds:Q61969570-E5B6E0B0-EB2B-4818-9F4C-481C69B841A7 wds:Q61969570-D1BA44B0-1C36-447C-8D2D-0ABE069CC1CE wds:Q61969570-DF963664-1315-4BF2-B1F8-F6D12A992CEF
wdt:P6153
wd:Q2892284 wd:Q5600442 wd:Q4821833 wd:Q5470801 wd:Q17066381 wd:Q812573 wd:Q30280592 wd:Q30270654 wd:Q1130172 wd:Q579968 wd:Q30281093
p:P1813
wds:Q61969570-3144405F-9C73-415B-93D7-892F02329976
wdt:P1813
MAGNIFY
p:P4844
wds:Q61969570-D77AB9A9-8BE2-445D-B690-FEF318CEA625 wds:Q61969570-956C077C-A33D-4BC2-91A5-94C30041A25A wds:Q61969570-A26546BB-AA35-499A-A599-501B7BAEA8F6
wdt:P4844
wd:Q425681 wd:Q412323 wd:Q203174
p:P2899
wds:Q61969570-B94D5F9F-5934-4CB5-98CC-1E14C8164ABB
wdt:P2899
18
p:P1050
wds:Q61969570-B011063F-4C34-4538-90A2-A7C7D39C9DB2
p:P131
wds:Q61969570-2F76C871-D984-4F2C-AFA1-0D195FB6F2AC
p:P859
wds:Q61969570-BEA531DA-22AB-4AB8-8FA5-6F5B1DBBA4EC
wdt:P1050
wd:Q208414
wdt:P131
wd:Q1183
wdt:P859
wd:Q842947
p:P1132
wds:Q61969570-634CC986-8AAC-4A1B-9BF5-FC1CA3D4256E
wdt:P1132
500
p:P8363
wds:Q61969570-A122426A-9831-47E7-9AC8-6F5442DCD0DC
wdt:P8363
wd:Q78089383
p:P3098
wds:Q61969570-67EA09DF-B17E-47D2-99CB-7134FBD61ABE
wdt:P3098
NCT01996865
p:P6099
wds:Q61969570-6806785F-4F0E-4C48-847F-3E4E69A99A55
wdt:P6099
wd:Q42824827